Register Here
TARGET AUDIENCE
Hematologists-oncologists, oncologists, physician assistants, nurse practitioners, and oncology nurses involved in the care of patients with acute myeloid leukemia (AML).
DATE
Monday, November 6, 2017
6:15pm – 9:00pm ET
LOCATION
DoubleTree Suites by Hilton Tampa Bay
3050 N. Rocky Point Dr. West
Tampa, FL 33607
CASE PRESENTATIONS
Management of the new patient with acute myeloid leukemia (AML)Management of the transplant patientNew treatment options for the patient with AMLLEARNING OBJECTIVES
At the conclusion of this program, participants will be able to:
Describe current and emerging treatments for AML
Identify diagnostic tests included in standard AML panels, and the role of cytogenetics & molecular analysis
•Use risk stratification for treatment planning•Engage patients & caregivers in clinical trials discussions on emerging therapies for AML•Apply strategies for optimal patient care
ADVISORY GROUP
Jeffrey E. Lancet, MD (Chair)
Moffitt Cancer Center
Wesam Ahmed, MD
Cleveland Clinic Florida
Christopher R. Cogle, MD
University of Florida
Meera Iyengar, MD
Florida Cancer Specialists
Daniel A. Landau, MD
University of Florida Health Cancer Center
Kendra Sweet, MD, MS
Moffitt Cancer Center
Lauren Berger, MPH
The Leukemia & Lymphoma Society
Seth Berkowitz, LCSW, CCLS
The Leukemia & Lymphoma Society
PROVIDERS
Jointly provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.
